about
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to s...
Read More
18.12
0.78
(4.50%)
422.6K
XNAS Volume
XNAS 17 Jul, 2026 1:05 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Vor Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..